PHOSPHODIESTERASE INHIBITORS - NEW OPPORTUNITIES FOR THE TREATMENT OF ASTHMA

被引：377

作者：

TORPHY, TJ ^{[1
]}

UNDEM, BJ ^{[1
]}

机构：

[1] JOHNS HOPKINS UNIV, SCH MED, DIV CLIN IMMUNOL, BALTIMORE, MD 21224 USA

来源：

关键词：

D O I：

10.1136/thx.46.7.512

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：512 / 523

页数：12

共 120 条

[1] APPLEMAN MM, 1982, HDB EXPT PHARM, V58, P262
[2] AVERILL LE, 1985, CLIN RES, V33, pA839
[3] ENDOGENOUS CATECHOLAMINES AND ASTHMA
BARNES, PJ
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1986, 77 (06) : 791 - 795
[4] BEAVO JA, 1970, J BIOL CHEM, V245, P5649
[5] BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1
[6] PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS
BEAVO, JA
REIFSNYDER, DH
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) : 150 - 155
[7] BERGSTRAND H, 1978, MOL CELL BIOCHEM, V21, P9
[8] BERGSTRAND H, 1980, EUR J RESPIR DIS, V61, P37
[9] BEUME R, 1987, ARCH PHARM S, V335, pR76
[10] BEWLEY JS, 1988, BRIT J PHARMACOL, V93, pP52